Works matching IS 21989788 AND DT 2022 AND VI 9 AND IP 4

Results: 16

Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 659, doi. 10.1007/s40801-022-00324-4

By:

Hasegawa, Shiori;
Ikesue, Hiroaki;
Satake, Riko;
Inoue, Misaki;
Yoshida, Yu;
Tanaka, Mizuki;
Matsumoto, Kiyoka;
Wakabayashi, Wataru;
Oura, Keita;
Muroi, Nobuyuki;
Hashida, Tohru;
Iguchi, Kazuhiro;
Nakamura, Mitsuhiro

Publication type:

Article

Prophylactic Antimicrobial Prescribing in Australian Residential Aged-Care Facilities: Improvement is Required.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 561, doi. 10.1007/s40801-022-00323-5

By:

Bennett, Noleen;
Malloy, Michael J.;
James, Rodney;
Fang, Xin;
Thursky, Karin;
Worth, Leon J.

Publication type:

Article

Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 577, doi. 10.1007/s40801-022-00320-8

By:

Scheid, Christof;
Kudernatsch, Robert;
Eckart, Marie;
Feig, Chiara;
Straub, Vincent;
Libutzki, Berit;
Mahlich, Jörg

Publication type:

Article

Retrospective Cohort Evaluating the Comparative Effectiveness of Ceftaroline and Daptomycin as First-Line Therapies for Inpatient Treatment of Diabetic Foot Infection in the United States Veterans Health Care System.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 609, doi. 10.1007/s40801-022-00319-1

By:

Eaves, Alyssa C.;
Teng, Chengwen;
Evoy, Kirk E.;
Frei, Christopher R.

Publication type:

Article

Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS Database.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 639, doi. 10.1007/s40801-022-00322-6

By:

Hillen, Jodie Belinda;
Stanford, Ty;
Ward, Michael;
Roughead, E. E.;
Kalisch Ellett, Lisa;
Pratt, Nicole

Publication type:

Article

Acknowledgement to Referees.

Published in:: Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 539, doi. 10.1007/s40801-022-00345-z
Publication type:: Article

Trends in the Use of Sedative-Hypnotics, Opioids, and Neuromuscular Blockers in Hospitalized Patients During the COVID-19 Pandemic: Observational Retrospective Study.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 629, doi. 10.1007/s40801-022-00337-z

By:

Machado-Duque, Manuel E.;
Gaviria-Mendoza, Andrés;
Valladales-Restrepo, Luis Fernando;
Albanés-Beltrán, Juan Pablo;
Machado-Alba, Jorge Enrique

Publication type:

Article

A Review of Research Studies Using Data from the Administrative Claims Databases in Japan.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 543, doi. 10.1007/s40801-022-00331-5

By:

Fujinaga, Jun;
Fukuoka, Toshio

Publication type:

Article

Drug-Induced QT Prolongation and Torsade de Pointes in Spontaneous Adverse Event Reporting: A Retrospective Analysis Using the Japanese Adverse Drug Event Report Database (2004–2021).

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 551, doi. 10.1007/s40801-022-00328-0

By:

Uchikawa, Mayu;
Hashiguchi, Masayuki;
Shiga, Tsuyoshi

Publication type:

Article

Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2− Metastatic Breast Cancer Treated with Abemaciclib.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 681, doi. 10.1007/s40801-022-00327-1

By:

Smyth, Emily Nash;
Beyrer, Julie;
Saverno, Kimberly R.;
Hadden, Elizabeth;
Abedtash, Hamed;
DeLuca, Angelo;
Lawrence, Garreth W.;
Rybowski, Sarah

Publication type:

Article

Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 617, doi. 10.1007/s40801-022-00326-2

By:

Mease, Philip J.;
Ogdie, Alexis;
Chakravarty, Soumya D.;
Shiff, Natalie J.;
Lin, Iris;
McLean, Robert R.;
Malley, Wendi;
Spitzer, Rebecca L.;
Kavanaugh, Arthur;
Merola, Joseph F.

Publication type:

Article

Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 649, doi. 10.1007/s40801-022-00325-3

By:

Uchiyama, Kiyotaka;
Kojima, Daiki;
Hama, Eriko Yoshida;
Nagasaka, Tomoki;
Nakayama, Takashin;
Takahashi, Rina;
Tajima, Takaya;
Morimoto, Kohkichi;
Washida, Naoki;
Itoh, Hiroshi

Publication type:

Article

Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 597, doi. 10.1007/s40801-022-00317-3

By:

Holthuis, Emily;
Smits, Elisabeth;
Spentzouris, George;
Beier, Dominik;
Enders, Dirk;
Gini, Rosa;
Bartolini, Claudia;
Mazzaglia, Giampiero;
Penning-van Beest, Fernie;
Herings, Ron

Publication type:

Article

Factors Associated with Discontinuation of Statin Therapy in Patients with Lymphoma Aged 80 Years and Older: A Retrospective Single-Institute Study.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 569, doi. 10.1007/s40801-022-00314-6

By:

Yamasaki, Satoshi;
Tokunou, Tomotake;
Horiuchi, Takahiko

Publication type:

Article

Adverse Drug Events Related to Common Asthma Medications in US Hospitalized Children, 2000–2016.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 667, doi. 10.1007/s40801-022-00304-8

By:

Xie, Luyu;
Gelfand, Andrew;
Mathew, Matthew S.;
Atem, Folefac D.;
Srikanth, Nimisha;
Delclos, George L.;
Messiah, Sarah E.

Publication type:

Article

Effectiveness and Safety of Filgrastim (Neupogen™) versus Filgrastim-aafi (Nivestim™) in Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia: An Observational Cohort Study.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 589, doi. 10.1007/s40801-022-00312-8

By:

Al-Rabayah, Abeer A.;
Al Mashni, Ola;
Hanoun, Esraa;
Al Qasem, Weam;
Al Momani, Deema;
Al Froukh, Rawan Fawzi;
Sawalha, Razan;
Hammoudeh, Suzan S.

Publication type:

Article